Sherbrooke Park Advisers’s RxSight RXST Stock Holding History

Sherbrooke Park Advisers’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,947	Closed	-$204K	–	891
2024 Q4	$204K	Buy	+5,947	New	+$268K	0.07%	580
2024 Q3	–	Sell	-5,208	Closed	-$313K	–	1216
2024 Q2	$313K	Sell	5,208 -186	-3%	-$10.6K	0.05%	606
2024 Q1	$278K	Buy	+5,394	New	+$265K	0.05%	593

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Sherbrooke Park Advisers's RXST Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of RxSight (RXST) in Q1 2025, closing a stake of 5,947 shares — an estimated $204K sold.

Sherbrooke Park Advisers first reported a position in RXST in Q1 2024 and held it in 3 quarters. The position peaked at $313K in Q2 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

Sherbrooke Park Advisers reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
Sherbrooke Park Advisers sold 5,947 RxSight shares in Q1 2025, an estimated $204K.
Sherbrooke Park Advisers first reported a position in RxSight in Q1 2024 and held it in 3 quarters.
Sherbrooke Park Advisers's RxSight position peaked at $313K in Q2 2024.
192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.